Assessing Post‐Marketing Requirements for Orphan Drugs: A Cross‐Sectional Analysis of <scp>FDA</scp> and <scp>EMA</scp> Oversight
2024 · Clinical Pharmacology & Therapeutics · 4 citations
https://doi.org/10.1002/cpt.3397
J
Jae Hyeon Yu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Jae Hyeon Yu is an academic researcher.
Papers by this author
worksChat about Author
Papers
Chat
Click to start Chat